%PDF-1.4
%
1 0 obj
<>stream
application/pdf
10.1080/14728222.2018.1452912
en
Interplay between the key proteins of serotonin system in SSRI antidepressants efficacy
Alexander V. Kulikov
Raul R. Gainetdinov
Evgeni Ponimaskin
Allan V. Kalueff
Vladimir S. Naumenko
Nina K. Popova
Taylor & Francis
Expert Opinion on Therapeutic Targets, 2018. doi:10.1080/14728222.2018.1452912
SSRI resistance
5-HT
tryptophan hydroxylase 2
5-HT transporter
5-HT1A receptor
5-HT7 receptor
gene polymorphism
gene knockout
Journal
Expert Opinion on Therapeutic Targets
© 2018 Informa UK Limited, trading as Taylor & Francis Group
1472-8222
1744-7631
22
4
319
330
10.1080/14728222.2018.1452912
https://doi.org/10.1080/14728222.2018.1452912
VoR
2018-04-10T20:16:10+05:30
Arbortext Advanced Print Publisher 11.0.3433/W Unicode
2018-04-17T21:41:34-07:00
2018-04-17T21:41:34-07:00
SSRI resistance; 5-HT; tryptophan hydroxylase 2; 5-HT transporter; 5-HT1A receptor; 5-HT7 receptor; gene polymorphism; gene knockout
iText 4.2.0 by 1T3XT
uuid:2033023e-c6f1-4c6c-9385-d7f58eab8926
uuid:8d036a9c-c2f9-439a-b67f-86ab1e5d6eb6
2018-04-04truewww.tandfonline.com10.1080/14728222.2018.1452912www.tandfonline.comtrue2018-04-0410.1080/14728222.2018.1452912
endstream
endobj
4 0 obj
<>stream
xYKl5ׯ $[B-UUW`bX3b6v$F4wsuung;uzCFSb'ty9}y4rk&
!\5/ǯg<>ޞLngG8]~ikޑ㲇P4w"k2B~5CsLlh\7Zb)"dN-.0|>@DGjrres
[BTNtb9ε
yj.ViI32遮)=}uN8PoGjttw鷟n~e7'g] hl*T+D?N?tiYNl`ki4}Mz,_zܵjEDMjݞJ6D>^9VL Bݥ-q/]~
+n!,;SO8 =erL+q_((ӡrG,rWT`"HHPȃ Gڢ L&ϓ5ąVn&e}&:C+6|MFB!o֏/WO |pۯXC;vDZ1T6V
aͅ'Ѣ>Alƞ(Qi3B.p^WMiM -/4T